120 related articles for article (PubMed ID: 8985208)
21. Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint.
Symons JA; McDowell TL; di Giovine FS; Wood NC; Capper SJ; Duff GW
Lymphokine Res; 1989; 8(3):365-72. PubMed ID: 2789325
[TBL] [Abstract][Full Text] [Related]
22. Depression of CD4 T cell subsets and alteration in cytokine profile in boutonneuse fever.
Cillari E; Milano S; D'Agostino P; Arcoleo F; Stassi G; Galluzzo A; Richiusa P; Giordano C; Quartararo P; Colletti P; Gambino G; Mocciaro C; Spinelli A; Vitale G; Mansueto S
J Infect Dis; 1996 Nov; 174(5):1051-7. PubMed ID: 8896508
[TBL] [Abstract][Full Text] [Related]
23. [Effects of smoking on interleukin-2 and its receptor system in human peripheral blood].
Jiao L; Gan D; Fang Y
Wei Sheng Yan Jiu; 1998 Nov; 27(6):385-8. PubMed ID: 11939024
[TBL] [Abstract][Full Text] [Related]
24. Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8, DR3 positive subjects.
Modica MA; di Lorenzo G; Galluzzo A; Giordano C; Portelli MR; Candore G; Caruso C
Autoimmunity; 1990; 7(2-3):87-96. PubMed ID: 2104185
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
26. IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.
Treiber-Held S; Stewart DM; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Apr; 79(1):71-8. PubMed ID: 8612353
[TBL] [Abstract][Full Text] [Related]
27. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-2 and soluble interleukin-2 receptor levels in children with active pulmonary tuberculosis and atypical mycobacterial adenitis.
Nyabenda J; Turneer M; Waelbroeck A; Duvivier A; Toppet M
Eur Cytokine Netw; 1993; 4(1):43-9. PubMed ID: 8490104
[TBL] [Abstract][Full Text] [Related]
29. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
[TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin-2 receptor release defect in vitro in elderly subjects.
Caruso C; Di Lorenzo G; Modica MA; Candore G; Portelli MR; Crescimanno G; Ingrassia A; Sangiorgi GB; Salerno A
Mech Ageing Dev; 1991 Jun; 59(1-2):27-35. PubMed ID: 1890884
[TBL] [Abstract][Full Text] [Related]
31. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
32. In vitro cytokine production by HLA-B8,DR3 positive subjects.
Candore G; Cigna D; Gervasi F; Colucci AT; Modica MA; Caruso C
Autoimmunity; 1994; 18(2):121-32. PubMed ID: 7742473
[TBL] [Abstract][Full Text] [Related]
33. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
34. Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
Caruso C; Modica MA; Candore G; Di Giulio C; Galluzzo A; Giordano C; Di Marco P; Gebbia V; Tamone Reyes M; Citarrella P
Boll Ist Sieroter Milan; 1990; 69(1):335-8. PubMed ID: 2102116
[TBL] [Abstract][Full Text] [Related]
35. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
37. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
[TBL] [Abstract][Full Text] [Related]
38. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.
Boyano MD; García-Vázquez MD; Gardeazabal J; García de Galdeano A; Smith-Zubiaga I; Cañavate ML; Raton JA; Bilbao I; Díaz-Pérez JL
Oncology; 1997; 54(5):400-6. PubMed ID: 9260602
[TBL] [Abstract][Full Text] [Related]
39. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
40. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
Frydecka I; Mazur G
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
